JD

John Dsouza

Active Director Director DIN 02531140
DIN 02531140 First appointment Mar 2009 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2009
Shareholding value •••• Premium profile

About John Dsouza

Data last updated:

John Dsouza is a Director at Pharmatech Equipments Private Limited (since 2009). The company operates in Healthcare. Pharmatech Equipments Private Limited reported revenue of ₹18.24 Cr (FY 2025).

DIN 02531140
Primary Designation Director
Industry Healthcare
First Appointment 24 Mar 2009
Oldest Company Age 17 yrs
Largest company Pharmatech Equipments Private Limited · ₹18.24 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director24 Mar 20092009₹18.24 Cr (FY 2025)Active

Board colleagues of John Dsouza

Directorship timeline

Open interactive timeline →
Pharmatech Equipments Private Limited
Premium access

Shareholding and investment profile for John Dsouza

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about John Dsouza

John Dsouza currently holds 1 directorship: Pharmatech Equipments Private Limited (Director, since 24 Mar 2009, revenue ₹18.24 Cr (FY 2025)).

John Dsouza was first appointed on 24 Mar 2009 as Director at Pharmatech Equipments Private Limited.

The current boards of John Dsouza's companies include Roywin John Dsouza (Pharmatech Equipments Private Limited), Rozin John Dsouza (Pharmatech Equipments Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available